Goodwin Procter has advised Merida Biosciences. Ropes & Gray has advised Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) and Merida Biosciences, Inc. have...
Eli Lilly to Acquire Merida Biosciences for Up To $2.875 Billion
Elara Caring Receives Strategic Investment from Ares’ Private Equity Group and DaVita
Skadden, Arps, Slate, Meagher & Flom LLP and Debevoise & Plimpton LLP have advised Elara Caring. Ropes & Gray LLP and McDermott Will & Emery LLP...
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion to Enhance Inflammatory Disease Portfolio
Ropes & Gray has advised Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati has advised Ventyx Biosciences. Gibson Dunn has advised Jefferies LLC as lead...
AbbVie Acquires Capstan Therapeutics in $2.1 Billion Deal to Expand Immunotherapy Portfolio
Ropes & Gray has advised AbbVie on the transaction, and Cooley has advised Capstan Therapeutics AbbVie has announced the acquisition of Capstan Therapeutics in a transaction...
Novartis’ $3.1 Billion Acquisition of Anthos Therapeutics
Goodwin Procter and Ropes & Gray represented Anthos Therapeutics in the transaction. Novartis announced its acquisition of Anthos Therapeutics, Inc. for up to $3.1 billion. Under...
AvenCell Therapeutics’ $112 Million Series B Funding Round
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
Cardinal Health’s $1.1 Billion Acquisition of Oncology Network
Ropes & Gray represented Cardinal Health in the transaction. Cardinal Health (NYSE: CAH) announced it has entered into an agreement to acquire Integrated Oncology Network (ION),...
Serán Bioscience’s $200 Million Growth Transaction
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
Rhythm Pharmaceuticals’ $150 Million Financing
Latham & Watkins is advising Rhythm Pharmaceuticals on the transaction, and Ropes & Gray is advising Perceptive Advisors LLC. Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (Rhythm), a commercial-stage...
Blackstone’s $1 Billion Financing Collaboration with PTC Therapeutics
WilmerHale advised PTC Therapeutics, while Ropes & Gray advised Blackstone on the deal. Blackstone announced a strategic financing collaboration for up to $1 billion in funding...
123Dentist’s Merger with Altima Dental
RBC Capital Markets acted as financial advisor to 123Dentist. KPMG LLP and E&Y LLP acted as accounting and tax advisors, Torys LLP acted as legal advisor...
CBC-led Consortium’s Acquisition of Controlling Stake in Hugel
Ropes & Gray represented Bain Capital in the transaction. Bain Capital completed the sale of its controlling stake in Hugel Inc., a leading biopharmaceutical company based in...